Do-Hyun Nam - Publications

Samsung Medical Center 

150 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Choi SW, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 31705245 DOI: 10.1007/s11060-019-03328-3  0.84
2019 Hwang K, Kim TM, Park CK, Chang JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, Hong YK, Kim EY, Lee DE, Joo J, Kim YJ, Choe G, et al. Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study). Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31671938 DOI: 10.4143/crt.2019.421  0.68
2019 Seo JH, Yang S, Kang MS, Her NG, Nam DH, Choi JH, Kim MH. Automated stitching of microscope images of fluorescence in cells with minimal overlap. Micron (Oxford, England : 1993). 126: 102718. PMID 31473399 DOI: 10.1016/j.micron.2019.102718  0.52
2019 Jeon C, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Outcome of three-fraction gamma knife radiosurgery for brain metastases according to fractionation scheme: preliminary results. Journal of Neuro-Oncology. PMID 31446529 DOI: 10.1007/s11060-019-03267-z  0.84
2019 Lee JJ, Kim HY, Dhong HJ, Chung SK, Kong DS, Nam DH, So YK, Hong SD. Delayed CSF Leakage after Treating Skull Base Tumors: Case Series of Nine Patients. World Neurosurgery. PMID 31442635 DOI: 10.1016/j.wneu.2019.08.067  0.84
2019 Jeon C, Park KA, Hong SD, Choi JW, Seol HJ, Nam DH, Lee JI, Shin HJ, Kong DS. Clinical efficacy of optical coherence tomography to predict the visual outcome after endoscopic endonasal surgery for suprasellar tumors. World Neurosurgery. PMID 31421301 DOI: 10.1016/j.wneu.2019.08.031  0.84
2019 Kim KH, Kong DS, Cho KR, Lee MH, Choi JW, Seol HJ, Kim ST, Nam DH, Lee JI. Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study. Journal of Neurosurgery. 1-10. PMID 31419791 DOI: 10.3171/2019.5.JNS19222  0.84
2019 Ju DG, Jeon C, Kim KH, Park KA, Hong SD, Seoul HJ, Shin HJ, Nam DH, Lee JI, Kong DS. Clinical significance of tumor-related edema of the optic tract affecting visual function in patients with sellar and suprasellar tumors. World Neurosurgery. PMID 31394363 DOI: 10.1016/j.wneu.2019.07.218  0.84
2019 Lee M, Kim YS, Lee K, Kang M, Shin H, Oh JW, Koo H, Kim D, Kim Y, Kong DS, Nam DH, Lee HW. Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models. Cancers. 11. PMID 31370279 DOI: 10.3390/cancers11081090  0.84
2019 Park HK, Yu DB, Sung M, Oh E, Kim M, Song JY, Lee MS, Jung K, Noh KW, An S, Song K, Nam DH, Kim YJ, Choi YL. Molecular changes in solitary fibrous tumor progression. Journal of Molecular Medicine (Berlin, Germany). PMID 31321477 DOI: 10.1007/s00109-019-01815-8  0.52
2019 Kim HY, Kim ST, Kim HJ, Jeon P, Byun HS, Kim YK, Cha J, Park GM, Nam DH, Kong DS. Differentiation of postoperative changes and residual tumors in dynamic contrast-enhanced sella MRI after transsphenoidal resection of pituitary adenoma. Medicine. 98: e16089. PMID 31277105 DOI: 10.1097/MD.0000000000016089  0.84
2019 Lee MH, Kim KH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning. Journal of Neurosurgery. 1-6. PMID 31151111 DOI: 10.3171/2019.3.JNS183130  0.84
2019 Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, Joung JG, Kim NKD, Son DS, Chung J, Lee T, ... ... Nam DH, et al. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31096737 DOI: 10.4143/crt.2019.036  0.84
2019 Teo WY, Sekar K, Seshachalam P, Shen J, Chow WY, Lau CC, Yang H, Park J, Kang SG, Li X, Nam DH, Hui KM. Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations. Scientific Reports. 9: 7442. PMID 31092847 DOI: 10.1038/s41598-019-43173-y  0.68
2019 Zhang J, Caruso FP, Sa JK, Justesen S, Nam DH, Sims P, Ceccarelli M, Lasorella A, Iavarone A. The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival. Communications Biology. 2: 135. PMID 31044160 DOI: 10.1038/s42003-019-0369-7  0.68
2019 Cho JH, Kim JS, Kim ST, Hong JY, Park JO, Park YS, Nam DH, Lee DW, Lee J. Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system. Plos One. 14: e0215080. PMID 30995234 DOI: 10.1371/journal.pone.0215080  0.6
2019 Lee M, Park C, Woo J, Kim J, Kho I, Nam DH, Park WY, Kim YS, Kong DS, Lee HW, Kim TJ. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme. Frontiers in Immunology. 10: 555. PMID 30967876 DOI: 10.3389/fimmu.2019.00555  0.84
2019 Yun JW, Bae YK, Cho SY, Koo H, Kim HJ, Nam DH, Kim SH, Chun S, Joo KM, Park WY. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with - Fusion. International Journal of Molecular Sciences. 20. PMID 30959925 DOI: 10.3390/ijms20071717  0.6
2019 Shin YJ, Sa JK, Lee Y, Kim D, Chang N, Cho HJ, Son M, Oh MYT, Shin K, Lee JK, Park J, Jo YK, Kim M, Paddison PJ, Tergaonkar V, ... ... Nam DH, et al. PIP4K2A as a negative regulator of PI3K in PTENdeficient glioblastoma. The Journal of Experimental Medicine. PMID 30898893 DOI: 10.1084/jem.20172170  0.68
2019 Jeon HY, Ham SW, Kim JK, Jin X, Lee SY, Shin YJ, Choi CY, Sa JK, Kim SH, Chun T, Jin X, Nam DH, Kim H. Ly6G inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model. Cell Death and Differentiation. PMID 30804471 DOI: 10.1038/s41418-019-0282-0  0.68
2019 Yang K, Jung SW, Shin H, Lim DH, Lee JI, Kong DS, Seol HJ, Kim ST, Nam DH. Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma - Radiogenomic approach for precision medicine. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 131: 66-74. PMID 30773189 DOI: 10.1016/j.radonc.2018.11.025  0.84
2019 Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, ... ... Nam DH, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Reports. 26: 1893-1905.e7. PMID 30759398 DOI: 10.1016/j.celrep.2019.01.076  0.52
2019 Lee MH, Kim J, Kim ST, Shin HM, You HJ, Choi JW, Seol HJ, Nam DH, Lee JI, Kong DS. Prediction of IDH1 Mutation Status in the Glioblastoma Using the Machine Learning Technique Based on the Quantitative Radiomic Data. World Neurosurgery. PMID 30735871 DOI: 10.1016/j.wneu.2019.01.157  0.84
2018 Seo MY, Nam DH, Kong DS, Lee JJ, Ryu G, Kim HY, Dhong HJ, Chung SK, Lee KE, Hong SD. Quality of life after extended versus transsellar endoscopic skull base surgery from 767 patients. The Laryngoscope. PMID 30569447 DOI: 10.1002/lary.27630  0.84
2018 Jeon C, Hong CK, Woo KI, Hong SD, Nam DH, Lee JI, Choi JW, Seol HJ, Kong DS. Endoscopic transorbital surgery for Meckel's cave and middle cranial fossa tumors: surgical technique and early results. Journal of Neurosurgery. 1-10. PMID 30544350 DOI: 10.3171/2018.6.JNS181099  0.84
2018 Sa JK, Choi SW, Zhao J, Lee Y, Zhang J, Kong DS, Choi JW, Seol HJ, Lee JI, Iavarone A, Rabadan R, Nam DH. Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations. International Journal of Cancer. PMID 30536544 DOI: 10.1002/ijc.32054  0.84
2018 D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, ... ... Nam DH, et al. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine. PMID 30531922 DOI: 10.1038/s41591-018-0263-8  0.48
2018 Lee MH, Hong SD, Woo KI, Kim YD, Choi JW, Seol HJ, Lee JI, Shin HJ, Nam DH, Kong DS. Endoscopic endonasal vs. transorbital surgery for middle cranial fossa tumors: Comparison of clinical outcomes based on surgical corridors. World Neurosurgery. PMID 30468930 DOI: 10.1016/j.wneu.2018.11.090  0.84
2018 Kim KH, Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. The influence of histology on the response of brain metastases to gamma knife radiosurgery: a propensity score-matched study. Acta Neurochirurgica. PMID 30413940 DOI: 10.1007/s00701-018-3726-2  0.84
2018 Kim BS, Kim ST, Kim JH, Seol HJ, Nam DH, Shin HJ, Lee JI, Kong DS. ADC value as a predictive biomarker for survival in patients with treatment-naïve glioblastoma using quantitative multiparametric MR profiling. World Neurosurgery. PMID 30391622 DOI: 10.1016/j.wneu.2018.10.151  0.84
2018 Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, ... ... Nam DH, et al. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. Cell. PMID 30343896 DOI: 10.1016/j.cell.2018.09.038  0.68
2018 Jeon C, Hong SD, Seol HJ, Lee JI, Nam DH, Hwang YJ, Kong DS. Corrigendum to "Reconstructive outcome of intraoperative cerebrospinal fluid leak after endoscopic endonasal surgery for tumors involving skull base" [J. Clin. Neurosci. 45 (2017) 227-231]. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30287251 DOI: 10.1016/j.jocn.2018.03.001  0.84
2018 Lee JK, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJ, Elliott O, Chu T, Choi SW, Rosenbloom DIS, Lee IH, Shin YJ, Kang HJ, Kim D, ... ... Nam DH, et al. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics. PMID 30262818 DOI: 10.1038/s41588-018-0209-6  0.84
2018 Wee CW, Kim IH, Park CK, Kim JW, Dho YS, Ohka F, Aoki K, Motomura K, Natsume A, Kim N, Suh CO, Chang JH, Kim SH, Cho WK, Lim DH, ... Nam DH, et al. Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 30236994 DOI: 10.1016/j.radonc.2018.09.001  0.72
2018 Kong DS, Young SM, Hong CK, Kim YD, Hong SD, Choi JW, Seol HJ, Lee JI, Shin HJ, Nam DH, Woo KI. Clinical and ophthalmological outcome of endoscopic transorbital surgery for cranioorbital tumors. Journal of Neurosurgery. 1-9. PMID 30215555 DOI: 10.3171/2018.3.JNS173233  0.84
2018 Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, ... ... Nam DH, et al. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nature Cell Biology. PMID 30202050 DOI: 10.1038/s41556-018-0183-3  0.68
2018 Lee YS, Choi JY, Lee J, Shim DM, Kim J, Park WY, Nam DH, Seo SW. TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 40: 1010428318794217. PMID 30124118 DOI: 10.1177/1010428318794217  0.6
2018 Won JS, Nam H, Lee HW, Hwang JY, Noh YJ, Nam DH, Lee SH, Joo KM. In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury. Plos One. 13: e0202307. PMID 30114270 DOI: 10.1371/journal.pone.0202307  0.68
2018 Cho HJ, Zhao J, Jung SW, Ladewig E, Kong DS, Suh YL, Lee Y, Kim D, Ahn SH, Bordyuh M, Kang HJ, Sa JK, Seo YJ, Kim ST, Lim DH, ... ... Nam DH, et al. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma. Neuro-Oncology. PMID 30085274 DOI: 10.1093/neuonc/noy123  0.84
2018 Lee KH, Pyeon HJ, Nam H, Won JS, Hwang JY, Lee KA, Yeon JY, Hong SC, Nam DH, Lee K, Lee SH, Joo KM. Significant therapeutic effects of adult human multipotent neural cells on spinal cord injury. Stem Cell Research. 31: 71-78. PMID 30031233 DOI: 10.1016/j.scr.2018.07.006  0.68
2018 Her NG, Oh JW, Oh YJ, Han S, Cho HJ, Lee Y, Ryu GH, Nam DH. Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells. Cell Death & Disease. 9: 792. PMID 30022047 DOI: 10.1038/s41419-018-0825-1  0.48
2018 Sa JK, Kim SH, Lee JK, Cho HJ, Shin YJ, Shin H, Koo H, Kim D, Lee M, Kang W, Hong SH, Kim JY, Park YW, Song SW, Lee SJ, ... ... Nam DH, et al. Identification of Genomic and Molecular Traits that Present Therapeutic Vulnerability to HGF-targeted therapy in Glioblastoma. Neuro-Oncology. PMID 29939324 DOI: 10.1093/neuonc/noy105  0.68
2018 Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y, Zhang S, Wang J, Komarova S, Wang J, Yamaguchi S, Alsheikh HA, Shi J, Chen D, Mohyeldin A, ... ... Nam DH, et al. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. Cancer Cell. PMID 29937354 DOI: 10.1016/j.ccell.2018.05.012  0.52
2018 Lee SY, Doh I, Nam DH, Lee DW. 3D cell-based high-content screening (HCS) using a micropillar and microwell chip platform. Analytical Chemistry. PMID 29889500 DOI: 10.1021/acs.analchem.7b05328  0.52
2018 Ham SW, Jeon HY, Jin X, Kim EJ, Kim JK, Shin YJ, Lee Y, Kim SH, Lee SY, Seo S, Park MG, Kim HM, Nam DH, Kim H. TP53 gain-of-function mutation promotes inflammation in glioblastoma. Cell Death and Differentiation. PMID 29786075 DOI: 10.1038/s41418-018-0126-3  0.52
2018 Kim KH, Kang SJ, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. Journal of Neurosurgery. 1-10. PMID 29775154 DOI: 10.3171/2017.12.JNS171943  0.84
2018 Kong DS, Hong CK, Hong SD, Nam DH, Lee JI, Seol HJ, Oh J, Kim DG, Kim YH. Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002). Journal of Neurosurgery. 1-10. PMID 29775151 DOI: 10.3171/2017.11.JNS171337  0.84
2018 Lee J, Kim D, Son E, Yoo SJ, Sa JK, Shin YJ, Yoon Y, Nam DH. Pharmacokinetics, Biodistribution, and Toxicity Evaluation of Anti-SEMA3A (F11) in Models. Anticancer Research. 38: 2803-2810. PMID 29715102  0.68
2018 deCarvalho AC, Kim H, Poisson LM, Winn ME, Mueller C, Cherba D, Koeman J, Seth S, Protopopov A, Felicella M, Zheng S, Multani A, Jiang Y, Zhang J, Nam DH, et al. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. Nature Genetics. PMID 29686388 DOI: 10.1038/s41588-018-0105-0  0.52
2018 Sim J, Nam DH, Kim Y, Lee IH, Choi JW, Sa JK, Suh YL. Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization. Medical Oncology (Northwood, London, England). 35: 60. PMID 29600313 DOI: 10.1007/s12032-018-1119-2  0.84
2018 Choi SW, Shin H, Sa JK, Cho HJ, Koo H, Kong DS, Seol HJ, Nam DH. Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma. Cancer Medicine. PMID 29573206 DOI: 10.1002/cam4.1439  0.84
2018 Jin P, Shin SH, Chun YS, Shin HW, Shin YJ, Lee Y, Kim D, Nam DH, Park JW. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway. Oncogene. PMID 29535421 DOI: 10.1038/s41388-018-0182-7  0.4
2018 Kim KH, Kim YH, Dho YS, Kim JH, Hong SD, Choi JW, Seol HJ, Nam DH, Lee JI, Park CK, Kong DS. Is low-lying optic chiasm an obstacle to endoscopic endonasal approach for retrochiasmatic craniopharyngiomas? (KOSEN-003). World Neurosurgery. PMID 29524705 DOI: 10.1016/j.wneu.2018.02.178  0.84
2018 Kim H, Lim DH, Kim TG, Lee JI, Nam DH, Seol HJ, Kong DS, Choi JW, Suh YL, Kim ST. Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact. Asia-Pacific Journal of Clinical Oncology. PMID 29473335 DOI: 10.1111/ajco.12861  0.84
2018 Kong DS, Kim J, Ryu G, You HJ, Sung JK, Han YH, Shin HM, Lee IH, Kim ST, Park CK, Choi SH, Choi JW, Seol HJ, Lee JI, Nam DH. Quantitative radiomic profiling of glioblastoma represents transcriptomic expression. Oncotarget. 9: 6336-6345. PMID 29464076 DOI: 10.18632/oncotarget.23975  0.84
2018 Kim BS, Kim Y, Kong DS, Nam DH, Lee JI, Suh YL, Seol HJ. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors. Journal of Neurosurgery. 1-13. PMID 29372881 DOI: 10.3171/2017.7.JNS171226  0.84
2018 Lee HM, Lee E, Yeo SY, Shin S, Park HK, Nam DH, Kim SH. Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis. Investigational New Drugs. PMID 29349597 DOI: 10.1007/s10637-017-0547-8  0.52
2018 Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Nam DH, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 33: 152. PMID 29316430 DOI: 10.1016/j.ccell.2017.12.012  0.52
2017 Jeong DE, Woo SR, Nam H, Nam DH, Lee JH, Joo KM. Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme. Oncology Letters. 14: 8213-8219. PMID 29344264 DOI: 10.3892/ol.2017.7196  0.6
2017 Lee DW, Lee SY, Doh I, Ryu GH, Nam DH. High-Dose Compound Heat Map for 3D-Cultured Glioblastoma Multiforme Cells in a Micropillar and Microwell Chip Platform. Biomed Research International. 2017: 7218707. PMID 29270434 DOI: 10.1155/2017/7218707  0.52
2017 Kim JY, Yu JH, Nam SJ, Kim SW, Lee SK, Park WY, Noh DY, Nam DH, Park YH, Han W, Lee JE. Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast. Translational Oncology. 11: 18-23. PMID 29145046 DOI: 10.1016/j.tranon.2017.10.002  0.44
2017 Lee J, Shin YJ, Lee K, Cho HJ, Sa JK, Lee SY, Kim SH, Lee J, Yoon Y, Nam DH. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress GBM Tumor Growth. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29129044 DOI: 10.4143/crt.2017.315  0.68
2017 Park H, Kim D, Son E, Shin S, Sa JK, Kim SH, Yoon Y, Nam DH. Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody. Biochemical and Biophysical Research Communications. PMID 28917835 DOI: 10.1016/j.bbrc.2017.09.061  0.68
2017 Park H, Kim D, Kim E, Sa JK, Lee HW, Yu S, Oh J, Kim SH, Yoon Y, Nam DH. Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain. International Journal of Molecular Sciences. 18. PMID 28902178 DOI: 10.3390/ijms18091968  0.68
2017 Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, Kwak C, Kim JB. RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer. Molecular and Cellular Biology. PMID 28827316 DOI: 10.1128/MCB.00265-17  0.68
2017 Jeon CM, Hong SD, Seol HJ, Lee JI, Nam DH, Hwang YJ, Kong DS. Reconstructive outcome of intraoperative cerebrospinal fluid leak after endoscopic endonasal surgery for tumors involving skull base. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 28765065 DOI: 10.1016/j.jocn.2017.07.012  0.84
2017 Yin J, Oh YT, Kim JY, Kim SS, Choi E, Kim TH, Hong JH, Chang N, Cho HJ, Sa JK, Kim JC, Kwon HJ, Park S, Lin W, Nakano I, ... ... Nam DH, et al. Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPβ signaling. Cancer Research. PMID 28754668 DOI: 10.1158/0008-5472.CAN-17-0388  0.68
2017 Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, ... ... Nam DH, et al. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. The Journal of Clinical Investigation. PMID 28737508 DOI: 10.1172/JCI89092  0.52
2017 Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Nam DH, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 32: 42-56.e6. PMID 28697342 DOI: 10.1016/j.ccell.2017.06.003  0.52
2017 Ryu SM, Lee JI, Park K, Choi JW, Kong DS, Nam DH, Jeong HS, Cho YS, Seol HJ. Optimal treatment of jugular foramen schwannomas: long-term outcome of a multidisciplinary approach for a series of 29 cases in a single institute. Acta Neurochirurgica. PMID 28589468 DOI: 10.1007/s00701-017-3230-0  0.84
2017 Kim YH, Jeon C, Se YB, Hong SD, Seol HJ, Lee JI, Park CK, Kim DG, Jung HW, Han DH, Nam DH, Kong DS. Clinical outcomes of an endoscopic transclival and transpetrosal approach for primary skull base malignancies involving the clivus. Journal of Neurosurgery. 1-9. PMID 28574308 DOI: 10.3171/2016.12.JNS161920  0.84
2017 Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. Journal of Neuro-Oncology. PMID 28536992 DOI: 10.1007/s11060-017-2478-9  0.84
2017 Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI, Lee SH, Nam DH, Kim SY, Kim KW, Kong DS, Kim YH. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly. World Neurosurgery. PMID 28465267 DOI: 10.1016/j.wneu.2017.04.141  0.84
2017 Cho SY, Park C, Na D, Han JY, Lee J, Park OK, Zhang C, Sung CO, Moon HE, Kim Y, Kim JH, Kim JJ, Khang SK, Nam DH, Choi JW, et al. High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. Experimental & Molecular Medicine. 49: e317. PMID 28408749 DOI: 10.1038/emm.2017.9  0.84
2017 Lee JK, Wang J, Sa JK, Ladewig E, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, Nieuwenhuizen PV, Jung SW, Choi SW, Kim J, Chen A, ... ... Nam DH, et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nature Genetics. PMID 28263318 DOI: 10.1038/ng.3806  0.84
2017 Mhetre AB, Lee H, Yang H, Lee K, Nam DH, Lim D. Synthesis and anticancer activity of benzoselenophene and heteroaromatic derivatives of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI). Organic & Biomolecular Chemistry. PMID 28090614 DOI: 10.1039/c6ob02729f  0.68
2017 Chang N, Ahn SH, Kong DS, Lee HW, Nam DH. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Molecular and Cellular Endocrinology. PMID 28089821 DOI: 10.1016/j.mce.2017.01.004  0.84
2017 Lee MH, Kong DS, Seol HJ, Nam DH, Lee JI. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery. Journal of Korean Neurosurgical Society. 60: 21-29. PMID 28061489 DOI: 10.3340/jkns.2016.0404.005  0.84
2016 Kim HR, Shin CH, Lee H, Choi KH, Nam DH, Ohn T, Kim HH. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3. Oncotarget. PMID 28039456 DOI: 10.18632/oncotarget.14184  0.64
2016 Sa JK, Lee IH, Hong SD, Kong DS, Nam DH. Genomic and transcriptomic characterization of skull base chordoma. Oncotarget. PMID 27901492 DOI: 10.18632/oncotarget.13616  0.84
2016 Lee S, Seo SW, Hwang J, Seol HJ, Nam DH, Lee JI, Kong DS. Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma. Cancer Medicine. PMID 27882725 DOI: 10.1002/cam4.955  0.84
2016 Hwang J, Kong DS, Seol HJ, Nam DH, Lee JI, Choi JW. Clinical and Radiological Characteristics of Angiomatous Meningiomas. Brain Tumor Research and Treatment. 4: 94-99. PMID 27867918 DOI: 10.14791/btrt.2016.4.2.94  0.84
2016 Hwang J, Seol HJ, Nam DH, Lee JI, Lee MH, Kong DS. Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System. Brain Tumor Research and Treatment. 4: 63-69. PMID 27867914 DOI: 10.14791/btrt.2016.4.2.63  0.84
2016 Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI. Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 27769643 DOI: 10.1016/j.jocn.2016.10.002  0.84
2016 Kong DS, Nam DH, Kang SH, Lee JW, Chang JH, Kim JH, Lim YJ, Koh YC, Chung YG, Kim JM, Kim CH. Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea. Oncotarget. PMID 27690294 DOI: 10.18632/oncotarget.12273  0.84
2016 Choi JW, Kong DS, Seol HJ, Nam DH, Yoo KH, Sun JM, Ahn JS, Ahn MJ, Park K, Lee JI. Outcomes of gamma knife radiosurgery in combination with crizotinib for patients with brain metastasis from non-small cell lung cancer. World Neurosurgery. PMID 27565474 DOI: 10.1016/j.wneu.2016.08.046  0.68
2016 Chang N, Lee HW, Lim JE, Jeong DE, Song HJ, Kim S, Nam DH, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion. Oncotarget. PMID 27438149 DOI: 10.18632/oncotarget.10539  0.68
2016 You HJ, Park HY, Kim J, Lee IH, Seol HJ, Lee JI, Kim ST, Kong DS, Nam DH. Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination. Medicine. 95: e4109. PMID 27399113 DOI: 10.1097/MD.0000000000004109  0.68
2016 Lee KH, Nam H, Jeong DE, Kim SS, Song HJ, Pyeon HJ, Kang K, Hong SC, Nam DH, Joo KM. Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction. Plos One. 11: e0158639. PMID 27391353 DOI: 10.1371/journal.pone.0158639  0.68
2016 Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, et al. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27384161 DOI: 10.4143/crt.2015.473  0.84
2016 Park W, Hong SD, Nam DH, Kong DS, Ryu G, Kim HY, Chung SK, Dhong HJ. Nasoseptal flap elevation in patients with history of septal surgery: Does it increase flap failure or cerebrospinal fluid leakage? World Neurosurgery. PMID 27302560 DOI: 10.1016/j.wneu.2016.06.006  0.68
2016 Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli M, Blumberg AJ, ... ... Nam DH, et al. Clonal evolution of glioblastoma under therapy. Nature Genetics. PMID 27270107 DOI: 10.1038/ng.3590  0.52
2016 Lee MH, Lee JH, Seol HJ, Lee JI, Kim JH, Kong DS, Nam DH. Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma. Brain Tumor Research and Treatment. 4: 1-7. PMID 27195254 DOI: 10.14791/btrt.2016.4.1.1  0.84
2016 Kim BS, Seol HJ, Lee JI, Shin HJ, Park K, Kong DS, Nam DH, Cho YS. Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges. Neurosurgical Review. PMID 27142681 DOI: 10.1007/s10143-016-0728-5  0.68
2016 Kim KT, Lee HW, Lee HO, Song HJ, Jeong DE, Shin S, Kim H, Shin Y, Nam DH, Jeong BC, Kirsch DG, Joo KM, Park WY. Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma. Genome Biology. 17: 80. PMID 27139883 DOI: 10.1186/s13059-016-0945-9  0.68
2016 Kim DG, Kim KH, Seo YJ, Yang H, Marcusson EG, Son E, Lee K, Sa JK, Lee HW, Nam DH. Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy. Oncotarget. PMID 27102443 DOI: 10.18632/oncotarget.8837  0.68
2016 Cho KR, Lee MH, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI. Gamma knife radiosurgery for trigeminal neuralgia secondary to benign lesions. Headache. PMID 27041354 DOI: 10.1111/head.12801  0.68
2016 Cho KR, Hong SD, Hur KY, Kim ST, Seol HJ, Lee JI, Kong DS, Nam DH. Serial re-expansion of pituitary gland is associated with endocrinological recovery. World Neurosurgery. PMID 27020971 DOI: 10.1016/j.wneu.2016.03.050  0.68
2016 Lee JK, Nam DH, Lee J. Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges. Oncology Letters. 11: 1281-1286. PMID 26893731 DOI: 10.3892/ol.2016.4074  0.68
2016 Kim HR, Lee JJ, Lee JI, Nam do H, Suh YL, Seol HJ. Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases. Journal of Korean Neurosurgical Society. 59: 44-51. PMID 26885285 DOI: 10.3340/jkns.2016.59.1.44  0.84
2016 Kong DS, Kim J, Lee IH, Kim ST, Seol HJ, Lee JI, Park WY, Ryu G, Wang Z, Ma'ayan A, Nam DH. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma. Oncotarget. PMID 26863628 DOI: 10.18632/oncotarget.7115  0.68
2016 Lee S, Seol HJ, Park K, Lee JI, Nam DH, Kong DS, Cho YS. Functional outcome of the facial nerve after surgery for vestibular schwannoma: Prediction of acceptable long-term facial nerve function based on immediate post-operative facial palsy. World Neurosurgery. PMID 26826537 DOI: 10.1016/j.wneu.2016.01.038  0.84
2016 Cho YJ, Kang W, Kim SH, Sa JK, Kim N, Paddison PJ, Kim M, Joo KM, Hwang YI, Nam DH. Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma. International Journal of Oncology. PMID 26783102 DOI: 10.3892/ijo.2016.3328  0.68
2015 Hong SD, Nam DH, Kong DS, Kim HY, Chung SK, Dhong HJ. Endoscopic Modified Transseptal Transsphenoidal Approach for Maximal Preservation of Sinonasal Quality of Life and Olfaction. World Neurosurgery. PMID 26732950 DOI: 10.1016/j.wneu.2015.12.050  0.68
2015 Lee SJ, Kang WY, Yoon Y, Jin JY, Song HJ, Her JH, Kang SM, Hwang YK, Kang KJ, Joo KM, Nam DH. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain. Bmc Cancer. 15: 1011. PMID 26704632 DOI: 10.1186/s12885-015-2034-y  0.68
2015 Park MC, Jeong H, Son SH, Kim YH, Han D, Goughnour PC, Kang T, Kwon NH, Moon HE, Paek SH, Hwang D, Seol HJ, Nam DH, Kim S. Novel morphological and genetic analysis of cancer cells in a 3D microenvironment identifies STAT3 as a regulator of tumor permeability barrier function. Cancer Research. PMID 26676754 DOI: 10.1158/0008-5472.CAN-14-2611  0.68
2015 Toledo CM, Ding Y, Hoellerbauer P, Davis RJ, Basom R, Girard EJ, Lee E, Corrin P, Hart T, Bolouri H, Davison J, Zhang Q, Hardcastle J, Aronow BJ, Plaisier CL, ... ... Nam DH, et al. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells. Cell Reports. PMID 26673326 DOI: 10.1016/j.celrep.2015.11.021  0.52
2015 Lee Y, Lee JK, Ahn SH, Lee J, Nam DH. WNT signaling in glioblastoma and therapeutic opportunities. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 26641068 DOI: 10.1038/labinvest.2015.140  0.68
2015 Lim Y, Yoo J, Kim MS, Hur M, Lee EH, Hur HS, Lee JC, Lee SN, Park TW, Lee K, Chang KH, Kim K, Kang Y, Hong KW, Kim SH, ... ... Nam DH, et al. GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands. Molecular Cancer Therapeutics. PMID 26586721 DOI: 10.1158/1535-7163.MCT-15-0679  0.4
2015 Lee HW, Lee K, Kim DG, Yang H, Nam DH. Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform. Histology and Histopathology. 11695. PMID 26578300 DOI: 10.14670/HH-11-695  0.68
2015 Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J, Shin K, Seo YJ, Choi YS, Lee JI, Lee J, Joo KM, Nam DH. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. Plos One. 10: e0137703. PMID 26444992 DOI: 10.1371/journal.pone.0137703  0.68
2015 Jeong DE, Song HJ, Lim S, Lee SJ, Lim JE, Nam DH, Joo KM, Jeong BC, Jeon SS, Choi HY, Lee HW. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget. PMID 26426994  0.68
2015 Cho KR, Lee MH, Kong DS, Seol HJ, Nam DH, Sun JM, Ahn JS, Ahn MJ, Park K, Kim ST, Lim DH, Lee JI. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer. Journal of Neuro-Oncology. PMID 26373297 DOI: 10.1007/s11060-015-1915-x  0.68
2015 Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, Nam SH, Kim BS, Johnson MD, Kong DS, Seol HJ, Lee JI, Joo KM, Yoon Y, Park WY, ... ... Nam DH, et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. Cancer Cell. 28: 318-28. PMID 26373279 DOI: 10.1016/j.ccell.2015.07.013  0.68
2015 Elkamhawy A, Viswanath AN, Pae AN, Kim HY, Heo JC, Park WK, Lee CO, Yang H, Kim KH, Nam DH, Seol HJ, Cho H, Roh EJ. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM). European Journal of Medicinal Chemistry. 103: 210-222. PMID 26355532 DOI: 10.1016/j.ejmech.2015.08.001  0.68
2015 Kang HC, Yu T, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Nam DH, Park CK, Hong YK, Kim IA. A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. Journal of Neuro-Oncology. PMID 26341368 DOI: 10.1007/s11060-015-1902-2  0.68
2015 Kang W, Kim SH, Cho HJ, Jin J, Lee J, Joo KM, Nam DH. Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of Glioblastoma multiforme. Oncotarget. PMID 26336988  0.6
2015 Kim DG, Jin Y, Jin J, Yang H, Joo KM, Lee WS, Shim SR, Kim SW, Yoo J, Lee SH, Yoo JS, Nam DH. Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis. Mabs. 0. PMID 26325365 DOI: 10.1080/19420862.2015.1086854  0.68
2015 Choi Y, Lim DH, Yu JI, Jo K, Nam DH, Seol HJ, Lee JI, Kong DS, Suh YL, Nam H. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma. American Journal of Clinical Oncology. PMID 26270441 DOI: 10.1097/COC.0000000000000224  0.84
2015 Lee DW, Lee MY, Ku B, Nam DH. Automatic 3D Cell Analysis in High-Throughput Microarray Using Micropillar and Microwell Chips. Journal of Biomolecular Screening. 20: 1178-84. PMID 26239238 DOI: 10.1177/1087057115597635  0.68
2015 Choi JW, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI. Effectiveness of Postoperative Gamma Knife Radiosurgery to the Tumor Bed after Resection of Brain Metastases. World Neurosurgery. PMID 26211856 DOI: 10.1016/j.wneu.2015.07.045  0.68
2015 Kong DS, Kim HR, Choi YR, Seol HJ, Lee JI, Nam DH. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 26138051 DOI: 10.1016/j.jocn.2015.02.036  0.68
2015 Kim KT, Lee HW, Lee HO, Kim SC, Seo YJ, Chung W, Eum HH, Nam DH, Kim J, Joo KM, Park WY. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biology. 16: 127. PMID 26084335 DOI: 10.1186/s13059-015-0692-3  0.68
2015 Lee JK, Chang N, Yoon Y, Yang H, Cho H, Kim E, Shin Y, Kang W, Oh YT, Mun GI, Joo KM, Nam DH, Lee J. USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance. Neuro-Oncology. PMID 26032834 DOI: 10.1093/neuonc/nov091  0.68
2015 Kim BS, Kim SK, Choi SH, Lee SH, Seol HJ, Nam DH, Lee JI, Park CK, Kong DS. Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas. Journal of Neuro-Oncology. 124: 101-10. PMID 26026859 DOI: 10.1007/s11060-015-1808-z  0.68
2015 Sa JK, Yoon Y, Kim M, Kim Y, Cho HJ, Lee JK, Kim GS, Han S, Kim WJ, Shin YJ, Joo KM, Paddison PJ, Ishitani T, Lee J, Nam DH. In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in Glioblastoma. Oncotarget. PMID 26023737  0.68
2015 Hong SD, Nam DH, Seol HJ, Choi NY, Kim HY, Chung SK, Dhong HJ. Endoscopic binostril versus transnasal transseptal microscopic pituitary surgery: Sinonasal quality of life and olfactory function. American Journal of Rhinology & Allergy. 29: 221-5. PMID 25975255 DOI: 10.2500/ajra.2015.29.4165  0.68
2015 Oh BY, Lee WY, Jung S, Hong HK, Nam DH, Park YA, Huh JW, Yun SH, Kim HC, Chun HK, Cho YB. Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients. Oncotarget. 6: 16059-68. PMID 25965827  0.68
2015 Lee WS, Pyun BJ, Kim SW, Shim SR, Nam JR, Yoo JY, Jin Y, Jin J, Kwon YG, Yun CO, Nam DH, Oh K, Lee DS, Lee SH, Yoo JS. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. Mabs. 0. PMID 25942475 DOI: 10.1080/19420862.2015.1045168  0.68
2015 Woo SR, Oh YT, An JY, Kang BG, Nam DH, Joo KM. Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness. Anatomy & Cell Biology. 48: 44-53. PMID 25806121 DOI: 10.5115/acb.2015.48.1.44  0.6
2015 Nabors LB, Fink KL, Mikkelsen T, Grujicic D, Tarnawski R, Nam do H, Mazurkiewicz M, Salacz M, Ashby L, Zagonel V, Depenni R, Perry JR, Hicking C, Picard M, Hegi ME, et al. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study. Neuro-Oncology. 17: 708-17. PMID 25762461 DOI: 10.1093/neuonc/nou356  0.68
2015 Lee HW, Choi HY, Joo KM, Nam DH. Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer. International Journal of Molecular Sciences. 16: 4471-91. PMID 25723737 DOI: 10.3390/ijms16034471  0.68
2015 Noh JH, Lee MH, Kim WS, Lim do H, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochirurgica. 157: 569-76. PMID 25663100 DOI: 10.1007/s00701-015-2344-5  0.68
2015 Nam H, Lee KH, Nam DH, Joo KM. Adult human neural stem cell therapeutics: Current developmental status and prospect. World Journal of Stem Cells. 7: 126-36. PMID 25621112 DOI: 10.4252/wjsc.v7.i1.126  0.6
2015 Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim do H, Lee JI. Outcome of salvage treatment for recurrent glioblastoma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 468-73. PMID 25595963 DOI: 10.1016/j.jocn.2014.09.018  0.68
2015 Lee HW, Lee JI, Lee SJ, Cho HJ, Song HJ, Jeong da E, Seo YJ, Shin S, Joung JG, Kwon YJ, Choi YL, Park WY, Lee HM, Seol HJ, Shim YM, ... ... Nam DH, et al. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1172-82. PMID 25549722 DOI: 10.1158/1078-0432.CCR-14-1589  0.68
2014 Hong SD, Nam DH, Park J, Kim HY, Chung SK, Dhong HJ. Olfactory outcomes after endoscopic pituitary surgery with nasoseptal "rescue" flaps: electrocautery versus cold knife. American Journal of Rhinology & Allergy. 28: 517-9. PMID 25514489 DOI: 10.2500/ajra.2014.28.4109  0.68
2013 Kang W, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors. Oncology Reports. 30: 1101-6. PMID 23828015 DOI: 10.3892/or.2013.2584  0.68
2013 Yang H, Lee HW, Kim Y, Lee Y, Choi YS, Kim KH, Jin J, Lee J, Joo KM, Nam DH. Radiosensitization of brain metastasis by targeting c-MET. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 344-53. PMID 23381625 DOI: 10.1038/labinvest.2012.180  0.84
2012 Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B, Kang YJ, Lathia JD, Cheong KH, Song PH, Kim H, Seol HJ, Kong DS, Lee JI, Rich JN, ... ... Nam DH, et al. MET signaling regulates glioblastoma stem cells. Cancer Research. 72: 3828-38. PMID 22617325 DOI: 10.1158/0008-5472.CAN-11-3760  0.68
2012 Jo MY, Kim YG, Kim Y, Lee SJ, Kim MH, Joo KM, Kim HH, Nam DH. Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms. Molecular Medicine Reports. 6: 88-92. PMID 22505191 DOI: 10.3892/mmr.2012.868  0.84
2012 Jung Y, Joo KM, Seong DH, Choi YL, Kong DS, Kim Y, Kim MH, Jin J, Suh YL, Seol HJ, Shin CS, Lee JI, Kim JH, Song SY, Nam DH. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. International Journal of Oncology. 40: 1122-32. PMID 22179774 DOI: 10.3892/ijo.2011.1302  0.84
2012 Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Wnt activation is implicated in glioblastoma radioresistance. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 466-73. PMID 22083670 DOI: 10.1038/labinvest.2011.161  0.84
2011 Seol HJ, Yoo HY, Jin J, Joo KM, Kim HS, Yoon SJ, Choi SH, Kim Y, Pyo HR, Lim DH, Kim W, Um HD, Kim JH, Lee JI, Nam DH. The expression of DNA damage checkpoint proteins and prognostic implication in metastatic brain tumors. Oncology Research. 19: 381-90. PMID 22329197  0.84
2011 Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam DH. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjugate Chemistry. 22: 2568-72. PMID 22070554 DOI: 10.1021/bc200406n  0.84
2011 Seol HJ, Jin J, Seong DH, Joo KM, Kang W, Yang H, Kim J, Shin CS, Kim Y, Kim KH, Kong DS, Lee JI, Aboody KS, Lee HJ, Kim SU, ... Nam DH, et al. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Letters. 311: 152-9. PMID 21868150 DOI: 10.1016/j.canlet.2011.07.001  0.68
2011 Kim KH, Yoo HY, Joo KM, Jung Y, Jin J, Kim Y, Yoon SJ, Choi SH, Seol HJ, Park WY, Nam do H. Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1229 lung cancer cell lines. Experimental & Molecular Medicine. 43: 419-26. PMID 21633183 DOI: 10.3858/emm.2011.43.7.046  0.84
2011 Lee SJ, Kim Y, Jo MY, Kim HS, Jin Y, Kim SU, Jin J, Joo KM, Nam DH. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response. Oncology Reports. 25: 63-8. PMID 21109958 DOI: 10.3892/or-00001042  0.68
2011 Jin J, Joo KM, Lee SJ, Jo MY, Kim Y, Jin Y, Kim JK, Ahn JM, Yoon MJ, Lim J, Nam DH. Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma. Oncology Reports. 25: 33-9. PMID 21109954 DOI: 10.3892/or-00001038  0.68
2009 Kim Y, Joo KM, Jin J, Nam DH. Cancer stem cells and their mechanism of chemo-radiation resistance. International Journal of Stem Cells. 2: 109-14. PMID 24855529  0.84
Show low-probability matches.